Published in J Med Genet on August 01, 2004
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci (2010) 1.87
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest (2008) 1.57
Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. Am J Respir Cell Mol Biol (2006) 1.39
Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med (2008) 1.29
The influence of genetics on cystic fibrosis phenotypes. Cold Spring Harb Perspect Med (2012) 1.07
Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis. J Med Genet (2006) 1.02
Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clin Exp Immunol (2006) 0.94
Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Thorax (2005) 0.90
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. Eur J Hum Genet (2010) 0.89
Genetic influences on cystic fibrosis lung disease severity. Front Pharmacol (2013) 0.88
Comparative analysis of common CFTR polymorphisms poly-T, TG-repeats and M470V in a healthy Chinese population. World J Gastroenterol (2008) 0.82
Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.81
The tumor necrosis factor α (-308 A/G) polymorphism is associated with cystic fibrosis in Mexican patients. PLoS One (2014) 0.75
Association of mannose-binding lectin 2 (mbl2) gene heterogeneity and its serum concentration with osteoporosis in postmenopausal women. Bosn J Basic Med Sci (2014) 0.75
The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet (1994) 4.94
A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet (1993) 2.64
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Length of gestation and birthweight in dizygotic twins. Lancet (2001) 2.33
Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet (2001) 2.13
Increased monozygotic twinning rate after ovulation induction. Lancet (1987) 2.12
Cystic fibrosis: terminology and diagnostic algorithms. Thorax (2005) 2.08
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology (1996) 2.08
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet (2006) 2.01
Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr (1998) 1.97
Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium) J Neurol Neurosurg Psychiatry (1998) 1.90
Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology (1997) 1.84
Validation of a telephone zygosity questionnaire in twins of known zygosity. Behav Genet (1998) 1.68
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Eur Respir J (2007) 1.66
Commitment to X inactivation precedes the twinning event in monochorionic MZ twins. Am J Hum Genet (1998) 1.61
Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia (2007) 1.56
Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy (2008) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Influence of weight-bearing exercises on bone acquisition in prepubertal monozygotic female twins: a randomized controlled prospective study. Calcif Tissue Int (2003) 1.50
Ultrastructural expression of primary ciliary dyskinesia after ciliogenesis in culture. Acta Otorhinolaryngol Belg (2000) 1.48
Pulmonary sequestration: a comparison between pediatric and adult patients. Eur J Cardiothorac Surg (2001) 1.46
European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol (2001) 1.44
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis (2001) 1.41
Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38
Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet (2000) 1.37
Evaluation of impulse oscillation system: comparison with forced oscillation technique and body plethysmography. Eur Respir J (2001) 1.37
Malformative syndrome associated with a ring 10 chromosome and a translocated 10q/19 chromosome. Hum Genet (1978) 1.34
Guiding periodontal pocket recolonization: a proof of concept. J Dent Res (2007) 1.33
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros (2011) 1.28
The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens (1997) 1.27
Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet (1992) 1.27
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros (2011) 1.23
Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens (1993) 1.22
The storage and use of biological tissue samples from minors for research: a focus group study. Public Health Genomics (2010) 1.21
Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg (1996) 1.20
Birth weight and body composition in young adult men--a prospective twin study. Int J Obes Relat Metab Disord (2001) 1.19
X chromosome-inactivation patterns confirm the late timing of monoamniotic-MZ twinning. Am J Hum Genet (1999) 1.18
Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut (2004) 1.17
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology (2001) 1.17
Iatrogenic multiple pregnancies in East Flanders, Belgium. Fertil Steril (1993) 1.16
Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet (1997) 1.15
A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet (1998) 1.14
A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry (1990) 1.13
Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab. Aliment Pharmacol Ther (2004) 1.13
Prenatal life and post-natal psychopathology: evidence for negative gene-birth weight interaction. Psychol Med (2002) 1.09
Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children. Eur Respir J (1998) 1.09
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut (2005) 1.08
Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol (1985) 1.06
The genetic contribution to dental maturation. J Dent Res (1997) 1.06
Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur J Hum Genet (2000) 1.06
Mutations in L1-CAM in two families with X linked complicated spastic paraplegia, MASA syndrome, and HSAS. J Med Genet (1995) 1.05
Bacteria interfere with A. actinomycetemcomitans colonization. J Dent Res (2007) 1.05
Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. Gastroenterology (2001) 1.05
Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet (1998) 1.05
Hypodontia and tooth formation in groups of children with cleft, siblings without cleft, and nonrelated controls. Cleft Palate Craniofac J (2001) 1.05
Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry (1997) 1.05
The Belgian PCB and dioxin incident of January-June 1999: exposure data and potential impact on health. Environ Health Perspect (2001) 1.05
Anticipation in familial Crohn's disease. Gut (1998) 1.04
SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. Hum Mol Genet (1997) 1.04
Prevalence of multiple sclerosis in Flanders, Belgium. Neuroepidemiology (1994) 1.03
Limited expansion of the (CAG)n repeat of the Huntington gene: a premutation (?). Eur J Hum Genet (1994) 1.02
Primary ciliary dyskinesia: evolution of pulmonary function. Eur J Pediatr (1998) 1.02
Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: is there a link with gastrointestinal complaints? J Pediatr Gastroenterol Nutr (2002) 1.02
Missense variations in the cystic fibrosis gene: heteroduplex formation in the F508C mutation. Am J Hum Genet (1992) 1.01
Czech dysplasia metatarsal type. Am J Med Genet A (2004) 1.01
Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator. J Physiol (1999) 1.00
Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol (1984) 0.99
Invasion and MMP expression profile in desmoid tumours. Br J Cancer (2004) 0.98
A quantitative study of unpaid caregiving in multiple sclerosis. Mult Scler (2000) 0.98
Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet (1999) 0.97
Study of fibroblasts in Marfan's syndrome. Humangenetik (1966) 0.97
Genetic and environmental variation in the birth weight of twins. Behav Genet (1989) 0.96
Genotype analysis of cystic fibrosis patients in relation to pancreatic sufficiency. Lancet (1990) 0.96
Mutation analysis in adenylosuccinate lyase deficiency: eight novel mutations in the re-evaluated full ADSL coding sequence. Hum Mutat (1999) 0.96
Epidemiology of interstitial lung disease (ILD) in flanders: registration by pneumologists in 1992-1994. Working group on ILD, VRGT. Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding. Acta Clin Belg (1995) 0.96
Quantitative trait loci for human muscle strength: linkage analysis of myostatin pathway genes. Physiol Genomics (2005) 0.95
Independent origins of cystic fibrosis mutations R334W, R347P, R1162X, and 3849 + 10kbC-->T provide evidence of mutation recurrence in the CFTR gene. Am J Hum Genet (1994) 0.95
Rapid detection of hypervariable regions by the polymerase chain reaction technique. DNA Cell Biol (1990) 0.94
Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax (2006) 0.94
The East Flanders Prospective Twin Survey (Belgium): a population-based register. Twin Res (1998) 0.94
Functional characterization of the CFTR R domain using CFTR/MDR1 hybrid and deletion constructs. Biochemistry (1999) 0.94
Birth weight and blood pressure in young adults: a prospective twin study. Circulation (2001) 0.93
A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett (1997) 0.93
Possible association of the allele status of the CS.7/HhaI polymorphism 5' of the CFTR gene with postnatal female survival. Hum Genet (1997) 0.93
Genetic variance of adolescent growth in stature. Ann Hum Biol (2000) 0.93
3-M syndrome in two sisters. J Paediatr Child Health (2002) 0.93
Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life. Mol Reprod Dev (2000) 0.93